The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
Abstract
Recent prospective investigations have reported that higher plasma fibrinogen concentrations and higher factor VII coagulant activity are associated with greater risk of cardiovascular disease. To discover what characteristics may influence fibrinogen and factor VII, we analyzed data from the Atherosclerosis Risk in Communities Study obtained from over 12,000 men and women, aged 45-64 years, from four communities in December 1986 to June 1989. Fibrinogen was higher in blacks than whites and in women than men; in general, it increased with age, smoking, body size, diabetes, fasting serum insulin, LDL cholesterol, lipoprotein(a), leukocyte count, and menopause, and it decreased with ethanol intake, physical activity, HDL cholesterol, and female hormone use. Factor VII was higher in women than men and, in women, increased with age; in both sexes, it increased with body size, triglycerides, LDL cholesterol, and HDL cholesterol, and it decreased with ethanol intake. These findings indicate that elevations in fibrinogen and factor VII may be modifiable through appropriate lifestyle changes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas the MS may play a limited role in accelerating atherosclerotic progression, it may significantly increase the risk of vascular events through prothrombotic or inflammatory mechanisms.29 -31”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [31]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239
(1989) · PubMed · Cited by 3,139
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645
Fibrinogen and risk of cardiovascular disease. The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387
Siedel, J., Hägele, E., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915
Cited by
Sorted by citations
Items 101–200 of 321
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors
Salomaa, V. V., Rasi, V., Pekkanen, J., Vahtera, E. M., Jauhiainen, M., Vartiainen, E. A., Ehnholm, C., Tuomilehto, J., & Myllylä, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1549 · Cited by 52
Lam, T. H., Liu, L. J., Janus, E. D., Bourke, C., & Hedley, A. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00294-9 · Cited by 52
Eliasson, M., Asplund, K., Evrin, P., Lindahl, B., & Lundblad, D. (1994) · Metabolism · doi:10.1016/0026-0495(94)90020-5 · Cited by 52
Breddin, H. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00056-8 · Cited by 51
Dotevall, A., Johansson, S., & Wilhelmsen, L. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90071-x · Cited by 50
Cardiorespiratory fitness and cardiovascular disease risk factors in postmenopausal women
Haddock, B. L., Hopp, H. P., Mason, J. J., Blix, G., & Blair, S. N. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199806000-00018 · Cited by 50
Bara, L., Nicaud, V., Tiret, L., Cambien, F., Samama, M. M., & On behalf of the EARS group (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642456 · Cited by 50
Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury
Daniel, R. M. (2005) · Frontiers in bioscience · doi:10.2741/1665 · Cited by 49
“Other studies, such as that conducted by Stock, et al (281), found that estrogen had little or no effect on spontaneous macrophage IL-1 secretion.”
BackgroundHaddock, B. L., Marshak, H. P. H., Mason, J. J., & Blix, G. (2000) · Sports Medicine · doi:10.2165/00007256-200029010-00004 · Cited by 49
Association of negative and positive social ties with fibrinogen levels in young women.
Davis, M. C., & Swan, P. D. (1999) · Health Psychology · doi:10.1037/0278-6133.18.2.131 · Cited by 48
Bilora, F., Rossi, C. D., Girolami, B., Casonato, A., Zanon, E., Bertomoro, A., & Girolami, A. (1999) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969900500405 · Cited by 48
“The increase of these clotting factors seems to be associated with a hypercoagulable state and/or an increased prevalence of thrombotic events (10-14).”
BackgroundMinimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study
Reed, T., Tracy, R. P., & Fabsitz, R. R. (1994) · Clinical Genetics · doi:10.1111/j.1399-0004.1994.tb03997.x · Cited by 48
Almendingen, K., Seljeflot, I., Sandstad, B., & Pedersen, J. I. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.375 · Cited by 48
Genetic determinants of arterial thrombosis
Grant, P. J., & Humphries, S. E. (1999) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0038 · Cited by 48
Association of Plasma γ′ Fibrinogen With Incident Cardiovascular Disease
Appiah, D., Schreiner, P. J., MacLehose, R. F., & Folsom, A. R. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306284 · Cited by 46
“Fibrinogen is also associated positively with several established CVD risk factors, so elevated fibrinogen may be one pathway by which these CVD risk factors exert their influence on the cardiovascular system.(4,6,7) Fibrinogen is a 6-chain molecule containing 2 copies each of the Aα, Bβ, and γ chains, with the latter…”
BackgroundSelf-citationSanders, T. A. B., de Grassi, T., Miller, G. J., & Humphries, S. E. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.2.220 · Cited by 46
The mechanisms of thrombotic risk induced by hormone replacement therapy
Cano, A., & van Baal, W. M. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00270-5 · Cited by 44
Maison, P., Mennen, L. I., Sapinho, D., Balkau, B., Sigalas, J., Chesnier, M.-C., & Eschwege, E. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00552-4 · Cited by 44
Lam, T., Liu, L. J., Janus, E. D., Lam, K. S. L., & Hedley, A. J. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00384.x · Cited by 43
Morano, M. T. A. P., Mesquita, R., Silva, G., Araújo, A. S., Pinto, J. M. D. S., Neto, A. G., Viana, C. M. S., de Moraes, M. O., & Pereira, E. D. B. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-121 · Cited by 43
“Most studies on the influence of physical activity on such blood components are conducted using trained athletes or athletes undergoing training [24,25], and two population-based studies show that physical activity lowers plasma fibrinogen concentration [26,27].”
BackgroundTessari, P., Kiwanuka, E., Millioni, R., Vettore, M., Puricelli, L., Zanetti, M., Gucciardi, A., Tosolini, M., Cogo, P. E., Carnielli, V. P., et al. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-0226 · Cited by 43
“No inflammatory or stress condition was detectable in our subjects, and they were not current smokers (26).”
BackgroundHalle, M., Berg, A., Keul, J., & Baumstark, M. W. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.144 · Cited by 43
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans
Austin, H. D., Hooper, W. C., Lally, C. A., Dilley, A., Ellingsen, D., Wideman, C. S., WENGER, N. K., Rawlins, P., Silva, V., & Evatt, B. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00191-8 · Cited by 43
Imhof, A., & Köenig, W. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70224-1 · Cited by 42
Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease
Pearson, T., LaCava, J., & Weil, H. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1674s · Cited by 42
Determinants of Population Changes in Fibrinogen and Factor VII Over 6 Years
Folsom, A. R., Wu, K. K., Rasmussen, M. L., Chambless, L. E., Aleksic, N., & Nieto, F. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.601 · Cited by 42
Self-citationWatts, E. L., Saint‐Maurice, P. F., Doherty, A., Fensom, G. K., Freeman, J. R., Gorzelitz, J., Jin, D., McClain, K. M., Papier, K., Patel, S., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.56186 · Cited by 42
Balasubramaniam, K., Viswanathan, G. N., Marshall, S. M., & Zaman, A. (2012) · Cardiology Research and Practice · doi:10.1155/2012/909154 · Cited by 41
“Increased circulating PMA percentage was found to be more specifically a marker of diabetic microretinopathy [97].”
BackgroundPostmenopausal Women and Cardiovascular Risk: Impact of Hormone Replacement Therapy
Rosano, G. M. C., & Fini, M. (2002) · Cardiology in Review · doi:10.1097/00045415-200201000-00010 · Cited by 40
Detection of Circulating Tissue Factor and Factor VII in a Normal Population
Albrecht, S., Kotzsch, M., Siegert, G., Luther, T., Großmann, H., Großer, M., & Müller, M. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650365 · Cited by 41
Infantile obesity: A situation of atherothrombotic risk?
Valle, M., Gascón, F., Martos, R., Ruz, F. J., Bermudo, F., Ríos, R., & Cañete, R. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80047-5 · Cited by 39
He, M., Wen, Z.-B., He, X., Xiong, S., Liu, F., Xu, J., Li, J., Xie, Q.-Z., Jian, Z.-F., Chen, F., et al. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00331-6 · Cited by 40
“Some studies have suggested that plasma FVII:C is a risk factor for ischemic heart disease [29] and AIS [30].”
BackgroundSmiles, A. M., Jenny, N. S., Tang, Z., Arnold, A. M., Cushman, M., & Tracy, R. P. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613057 · Cited by 40
“Multivariate prediction models have been previously reported for another VKDP, factor VII, in both elderly and middle aged populations (51, 52).”
MethodSaha, N., Liu, Y., Heng, C., Hong, S., Low, P., & Tay, J. S. H. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1923 · Cited by 40
Avellone, G., Garbo, V. D., Cordova, R., Raneli, G., Simone, R. D., & Bompiani, G. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90233-x · Cited by 40
Chien, K., Lee, Y., Sung, F., Su, T., Hsu, H., & Lin, R. S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00298-6 · Cited by 39
“Other studies reported significant associations between Lp(a) levels and fibrinogen levels in females rather than in males [23,37,38].”
BackgroundTessari, P., Kiwanuka, E., Barazzoni, R., Vettore, M., & Zanetti, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0288-2 · Cited by 39
Haemostatic parameters and vascular risk
Juhan-Vague, I. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05857-1 · Cited by 37
Chen, F.-P., Lee, N., Soong, Y.-K., & Huang, K. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200109000-00009 · Cited by 39
Mellen, P. B., Cefalu, W. T., & Herrington, D. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191656.71812.7c · Cited by 38
Role of thrombotic and fibrinolytic factors in acute coronary syndromes
Saigo, M., Hsue, P. Y., & Waters, D. D. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.02.003 · Cited by 38
Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk In Communities (ARIC) Study
Folsom, A. R., Peacock, J. M., Nieto, F. J., Rosamond, W. D., Eigenbrodt, M. L., DAVIS, C. E., & Wu, K. K. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00003 · Cited by 37
Self-citationMcCarty, M. F. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90243-1 · Cited by 37
Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women
Rankinen, T., Rauramaa, R., Väisänen, S., Penttilaä, I., Saarikoski, S., Tuomilehto, J., & Nissinen, A. M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90160-v · Cited by 37
Ghaddar, H. M., Folsom, A. R., Aleksic, N., Hearne, L. B., Chambless, L. E., Morrissey, J. H., & Wu, K. K. (1998) · Circulation · doi:10.1161/01.cir.98.25.2815 · Cited by 36
Self-citationLipoproteins and the haemostatic system in atherothrombotic disorders
Miller, G. J. (1999) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0040 · Cited by 36
Persistent smokers after myocardial infarction: a group that requires special attention
Rallidis, L. S., Hamodraka, E. S., Foulidis, V., & Pavlakis, G. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.08.040 · Cited by 35
Job conditions and fibrinogen in 14226 Belgian workers. The Belstress study
Kittel, F. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3258 · Cited by 36
“The higher fibrinogen values in women than in men [24] [26] [27] , the positive association with age [24] [26] [35] , obesity [19,24–26] , smoking status [17–19,24,29,35] , serum chol- esterol [27] [28] , hypertension [24] and diabetes [26] has been documented for both sexes, as has been the…”
BackgroundResultInfluentialDietary treatment of thrombogenic disorders related tothe metabolic syndrome
Marckmann, P. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500001057 · Cited by 37
“1983; Folsom et al. 1993; Lindahlet al. 1998, 1999; Ja ̈rvi et al. 1999). We studied 36 obese individuals, mostly females, who were slimmed on low-calorie diets over 4–8 weeks and who were then weight maintained on diets moderately low in total fat (Marckmannet al. 1998b). After an average weight loss of 14 kg and 24…”
Controversies regarding hormone therapy: Insights from inflammation and hemostasis
Koh, K. K., & Yoon, B. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.004 · Cited by 34
“However, effects of aging, independent of estrogen status, also likely contribute to these changes [45,46].”
BackgroundMcDermott, M. M., Greenland, P., Guralnik, J. M., Ferrucci, L., Green, D., Liu, K., Criqui, M. H., Schneider, J. R., Chan, C., Ridker, P. M., et al. (2004) · Vascular Medicine · doi:10.1191/1358863x04vm525oa · Cited by 34
Fibrinogen in Human Atherosclerosis
Bini, A., & Kudryk, B. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17342.x · Cited by 35
Pankow, J. S., Folsom, A. R., Province, M. A., Rao, D. C., Williams, R. R., Eckfeldt, J. H., & Sellers, T. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.10.1559 · Cited by 34
Self-citationPATEL, J. V., TRACEY, I., HUGHES, E. A., & LIP, G. Y. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03956.x · Cited by 32
Association of depressive symptoms with coagulation factors in young healthy individuals
Doulalas, A. D., Rallidis, L. S., Gialernios, T. P., Moschonas, D., Kougioulis, M. N., Rizos, I., Tselegaridis, T. S., & Kremastinos, D. T. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.030 · Cited by 32
Cowan, L. D., Go, O. T., Howard, B. V., Devereux, R. B., Pettitt, D. J., FABSITZ, R. R., Lee, E. T., & Welty, T. K. (1997) · Journal of Women s Health · doi:10.1089/jwh.1997.6.441 · Cited by 32
Sinha, S., Luben, R., Welch, A. A., Bingham, S. A., Wareham, N. J., Day, N. E., & Khaw, K. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200504000-00009 · Cited by 31
Plasma fibrinogen of black South Africans: the BRISK study
Vorster, H., Jerling, J. C., Steyn, K., Cj, B., Slazus, W., Venter, C., Jooste, P. L., & Bourne, L. (1998) · Public Health Nutrition · doi:10.1079/phn19980026 · Cited by 31
Ibáñez, L., Aulesa, C., Potau, N., Ong, K. K., Dunger, D. B., & de Zegher, F. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00019 · Cited by 31
“Long-term hyperinsulinemia is known to increase circulating fibrinogen levels (26, 53).”
BackgroundThe menopause and its treatment in perspective
Al‐Azzawi, F. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.907.292 · Cited by 28
“The menopause results in changes in coagulation factors, with increases in fibrinogen,”
BackgroundMENOPAUSE AND RISK OF CARDIOVASCULAR DISEASE
Gensini, G. F., Micheli, S., Prisco, D., & Abbate, R. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00143-0 · Cited by 30
Anderssen, S. A., Holme, I., Urdal, P., & Hjermann, I. (1998) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.1998.tb00177.x · Cited by 30
Bonithon‐Kopp, C., Levenson, J. A., Scarabin, P., Guillanneuf, M.-T., Kirzin, J.-M., Malméjac, A., & Guize, L. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90188-z · Cited by 30
Plasma Fibrinogen and Its Correlates in Children from a Biracial Community: The Bogalusa Heart Study
Bao, W., Srinivasan, S. R., & Berenson, G. S. (1993) · Pediatric Research · doi:10.1203/00006450-199304000-00003 · Cited by 30
Otto, C., Ritter, M. M., Richter, W. O., Minkenberg, R., & SCHWANDT, P. (2001) · Metabolism · doi:10.1053/meta.2001.20192 · Cited by 29
Folsom, A. R., Pankow, J. S., Williams, R. R., Evans, G. W., Province, M. A., & Eckfeldt, J. H. (1998) · PubMed · Cited by 29
Self-citationDiet and blood coagulation factor VII—a key protein in arterial thrombosis
Marckmann, P., Bladbjerg, E., & Jespersen, J. (1998) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600533 · Cited by 29
“Smoking seems to have no in¯uence (Balleisen et al, 1985; Folsom et al, 1991).”
BackgroundInfluentialStudy of fibrinogen in patients with diabetes mellitus.
Dr, K., & Shrestha, P. L. (2010) · PubMed · Cited by 28
Lindeberg, S., Berntorp, E. E., Carlsson, R., Eliasson, M., & Marckmann, P. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655913 · Cited by 28
“raised by smoking and lowered by abstention in Westerners, and since a dose-dependent positive association between fibrinogen and smoking has been found in males in several large surveys, while in females the difference has been small or absent (17, 24, 39, 40).”
BackgroundResultInfluential14 Lipoproteins and the haemostatic system in atherothrombotic disorders
Miller, G. J. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80105-2 · Cited by 28
Cardiovascular disease and heritability of the prothrombotic state
Ajjan, R., & Ariëns, R. A. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.07.001 · Cited by 27
Circulating fibrinogen but not d -dimer level is associated with vital exhaustion in school teachers
Kudielka, B. M., Bellingrath, S., & von Känel, R. (2008) · Stress · doi:10.1080/10253890701714831 · Cited by 26
“We controlled for gender, age, BMI, seasonality (month of laboratory visit), tobacco smoking status (yes/no), alcohol consumption (number of days alcohol was consumed in a typical week), physical activity (physical exercise per week in hours), MAP, total serum cholesterol, fasting serum glucose and depressive symptoma…”
MethodCIGOLINI, M., Targher, G., Sandre, G. D., Muggeo, M., & Seidell, J. C. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00977.x · Cited by 27
12 Genetic determinants of arterial thrombosis
Green, F. R., & Humphries, S. E. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80103-9 · Cited by 27
Vorster, H. H. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00033-x · Cited by 26
Ács, N., Vajó, Z., Miklós, Z., Siklósi, G., Paulin, F., Felicetta, J. V., & Székács, B. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.4.335.346 · Cited by 26
Cardiovascular Pharmacology of Hormone Replacement Therapy
Rosano, G. M. C., & Panina, G. (1999) · Drugs & Aging · doi:10.2165/00002512-199915030-00005 · Cited by 26
Increased Fibrinogen Levels in the Offspring of Hypertensive Men
Válek, J., Válková, L., Vlasáková, Z., & Topinka, V. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2229 · Cited by 26
Diet and haemostatic processes
Vorster, H. H., Cummings, J. H., & Jerling, J. C. (1997) · Nutrition Research Reviews · doi:10.1079/nrr19970007 · Cited by 25
Nutrition and coronary heart disease
Hankey, C. R., & Leslie, W. S. (2001) · Coronary Health Care · doi:10.1054/chec.2001.0143 · Cited by 25
Hiramoto, J. S., Owens, C. D., Kim, J. M., Boscardin, W. J., Belkin, M., Creager, M. A., & Conte, M. S. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.01.059 · Cited by 25
The relationship between employment grade and plasma fibrinogen level among Japanese male employees
Ishizaki, M., Martikainen, P., Nakagawa, H., & Marmot, M. G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00414-1 · Cited by 24
“The presence of inflammation is well known for being closely related to increased plasma fibrinogen and WBC [18,31].”
BackgroundRelationship between Triglycerides and Factor VIIc and Plasminogen Activator Inhibitor Type-1
Chadarévian, R., Bruckert, É., Dejager, S., Cohen-Presberg, P., & Turpin, G. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00089-4 · Cited by 24
Arai, Y., Hirose, N., Yamamura, K., Kimura, M., Murayama, A., Fujii, I., & Tsushima, M. (2002) · Angiology · doi:10.1177/000331970205300108 · Cited by 24
Fibrinogen, fibrinolysis and diabetes mellitus: a comment
Vague, P., & Juhan-Vague, I. (1997) · Diabetologia · doi:10.1007/s001250050743 · Cited by 22
“In non-diabetic subjects, a weak correlation has been observed with plasma insulin level [13‐15], BMI [ 16 ], waist-tohip ratio [17, 18], hyperlipidaemia [19], as well as hypertension [20], all parameters clustering in the insulin resistance syndrome.”
BackgroundPhysical activity according to ethnic origin in Finnmark county, Norway. The Finnmark Study
Hermansen, R., Njølstad, I., & Fønnebø, V. M. (2002) · International Journal of Circumpolar Health · doi:10.3402/ijch.v61i3.17452 · Cited by 21
“plasma fibrinogen (15-17), lowers blood pressure (8,1820) and induces weight loss (21).”
BackgroundCole, D. E. C., Fukuda, S., Gordon, B. A., Rip, J. W., LeCouteur, A. N., Rupar, C. A., Tomatsu, S., Ogawa, T., Sukegawa, K., & Orii, T. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960628)63:4 · Cited by 17
Factor VII, Cholesterol, and Triglycerides
Green, D., Chamberlain, M., Ruth, K. J., Folsom, A. R., & Liu, K. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.51 · Cited by 20
Self-citationAtherothrombotic Risk Factors in Subjects with a Family History of Stroke
Lansbury, A. J., Grant, P. J., & Catto, A. J. (2002) · Cerebrovascular Diseases · doi:10.1159/000065677 · Cited by 19
Plasma fibrinogen concentration in a Chinese population
Ko, G. T. C., Yeung, M. W., Chan, J. C. N., Chow, C., Li, J. K. Y., So, W.-Y., Tsang, L. W. W., & Cockram, C. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06109-1 · Cited by 19
“As in other studies, we found positive correlations between plasma fibrinogen and increasing age [19–22], hypertension and obesity [19,20].”
BackgroundResultSaha, N., Heng, C., Mozoomdar, B. P., Reuben, E. M., Soh, H. T., Low, P., Tay, J. S. H., Liu, Y., & Hong, S. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05554-a · Cited by 19
Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration
Hegele, R. A., Breckenridge, W. C., Brunt, J., & Connelly, P. W. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1701 · Cited by 19
Reference values for activated coagulation time in cats
Bay, J. D., Scott, M. A., & Hans, J. E. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.750 · Cited by 18
Symptoms of chronic bronchitis, haemostatic factors, and coronary heart disease risk
Jousilahti, P., Salomaa, V. V., Rasi, V., & Vahtera, E. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00248-2 · Cited by 18
“Several life style factors, such as smoking, obesity, physical exercise, and socio-economic status have also been shown to affect the levels of haemostatic factors [9,10].”
BackgroundThrombophilia in patients with hypercholesterolemia
Chan, P., Tomlinsoin, B., Tsai, C.-W., Pan, W., & Lee, Y.-S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90264-4 · Cited by 18
Plasma Fibrinogen and its Correlates in Urban Japanese Men
Sato, S., Iso, H., Naito, Y., Kiyama, M., Kitamura, A., Iida, M., Shimamoto, T., & Komachi, Y. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.3.521 · Cited by 18
Cobbaert, C. M., Mulder, P. G. H., Lindemans, J. W., & Kesteloot, H. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00129-7 · Cited by 17
Frontini, M., Srinivasan, S. R., Elkasabany, A., & Berenson, G. S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00538-4 · Cited by 17
“For example, higher triglyceride levels are accompanied by raised factor VII, fibrinogen, and plasminogen activator inhibitor type 1 [44–47], as part of the insulin resistance syndrome [48,49].”
BackgroundThe genetic contribution to the risk of thrombosis and cardiovascular disease
Humphries, S. E. (1994) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(94)90020-5 · Cited by 17
“As well as the effect of dietary lipid intake, a number of other factors influence factor VIIc levels (Folsom et al. 1991).”
Background
Metadata
- Authors
- FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M.
- Affiliations
- University of Minnesota (US)
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- Corresponding author
- FOLSOM, A
- Venue
- Atherosclerosis
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 91
- Issue
- 3
- Pages
- 191-205
- ISSN
- 0021-9150 (ISSN-L)
- OpenAlex
- W2001322531
- Cited by
- 321
- References
- 52
- Citations by year
- 2024: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 6
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Atherosclerosis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Northwestern University
- National Institutes of Health (n01hc55016-37-0-0, n01hc55018-38-0-1, n01hc55015-48-0-1)
- National Heart, Lung, and Blood Institute (N01-HC-55018, N01-HC55016, N01‐HC‐55015)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- fibrinogen, factor VII coagulant activity, cardiovascular risk factors, cardiovascular disease, Atherosclerosis Risk in Communities Study, sex differences, racial differences, modifiable lifestyle factors, smoking, alcohol consumption, physical activity, diabetes mellitus, insulin, lipoprotein(a), LDL cholesterol, HDL cholesterol, triglycerides, menopause, white blood cell count, aging
- MeSH terms
- Body Constitution, Cardiovascular Diseases, Coronary Disease, Factor VII, Female, Fibrinogen, Humans, Life Style, Lipids, Male, Middle Aged, Prospective Studies, Risk Factors, Sex Factors, Smoking, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review